Literature DB >> 29808247

Down-Regulated LncRNA-HOTAIR Suppressed Colorectal Cancer Cell Proliferation, Invasion, and Migration by Mediating p21.

Kai Lin1, Hong Jiang2, Ling-Ling Zhang3, Yi Jiang4, Yu-Xian Yang4, Guo-Dong Qiu5, Yu-Qi She5,6, Jie-Ting Zheng5, Chen Chen5, Ling Fang5, Shu-Yao Zhang7,8.   

Abstract

BACKGROUND AND AIM: HOX transcript antisense intergenic RNA (HOTAIR) is a relatively well-understood RNA, which plays a central role in the pathogenesis of various tumors. The aim of the present study was to investigate the effect by which HOTAIR acts to influence the biological processes of colorectal cancer (CRC) through p21.
METHODS: Reverse transcription quantitative polymerase chain reaction and Western blot methods were employed to provide verification regarding the changes in HOTAIR, PCNA, Ki67, p21, cyclin E, and CDK2 among the CRC tissues and cells. The correlation between the clinicopathological characteristics of patients and expression of HOTAIR and p21 was subsequently evaluated, followed by an analysis into the effects of HOTAIR on the biological processes of M5 cells.
RESULTS: HOTAIR was found to be expressed at high levels, while p21 was determined to be at a low level among both the CRC tissues and the CRC cell lines. The expressions of HOTAIR and p21 were determined to be related to lymph node metastasis, tumor node metastasis, Dukes staging, distant metastases, histological types, and the degree of differentiation. Cells transfected with HOTAIR siRNA displayed inhibited rates of proliferation, invasion, and migration, as well as decreased cyclin E and CDK2, while apoptosis and p21 were increased.
CONCLUSION: The principal findings demonstrated that down-regulation of HOTAIR elicits an inhibitory effect on proliferation, invasion, and migration, while promoting the apoptosis of CRC cells through the up-regulation of p21. We believe that HOTAIR could represent a novel target for the treatment of CRC.

Entities:  

Keywords:  Colorectal cancer; HOX transcript antisense RNA; Invasion; Migration; Proliferation; p21

Mesh:

Substances:

Year:  2018        PMID: 29808247     DOI: 10.1007/s10620-018-5127-z

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  23 in total

1.  Clinical significance of long intergenic noncoding RNA-p21 in colorectal cancer.

Authors:  Haiyan Zhai; Andrew Fesler; Kristina Schee; Oystein Fodstad; Kjersti Flatmark; Jingfang Ju
Journal:  Clin Colorectal Cancer       Date:  2013-09-05       Impact factor: 4.481

Review 2.  The predictive value of KRAS, NRAS, BRAF, PIK3CA and PTEN for anti-EGFR treatment in metastatic colorectal cancer: A systematic review and meta-analysis.

Authors:  Christina Therkildsen; Troels K Bergmann; Tine Henrichsen-Schnack; Steen Ladelund; Mef Nilbert
Journal:  Acta Oncol       Date:  2014-03-25       Impact factor: 4.089

3.  Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers.

Authors:  Ryunosuke Kogo; Teppei Shimamura; Koshi Mimori; Kohichi Kawahara; Seiya Imoto; Tomoya Sudo; Fumiaki Tanaka; Kohei Shibata; Akira Suzuki; Shizuo Komune; Satoru Miyano; Masaki Mori
Journal:  Cancer Res       Date:  2011-08-23       Impact factor: 12.701

4.  Biological significance of long non-coding RNA FTX expression in human colorectal cancer.

Authors:  Xiao-Bo Guo; Zhu Hua; Chen Li; Li-Pan Peng; Jing-Shen Wang; Bo Wang; Qiao-Ming Zhi
Journal:  Int J Clin Exp Med       Date:  2015-09-15

5.  High-dose-rate intraoperative brachytherapy for recurrent colorectal cancer.

Authors:  K M Alektiar; M J Zelefsky; P B Paty; J Guillem; L B Saltz; A M Cohen; B D Minsky
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-08-01       Impact factor: 7.038

6.  KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer.

Authors:  Astrid Lièvre; Jean-Baptiste Bachet; Delphine Le Corre; Valérie Boige; Bruno Landi; Jean-François Emile; Jean-François Côté; Gorana Tomasic; Christophe Penna; Michel Ducreux; Philippe Rougier; Frédérique Penault-Llorca; Pierre Laurent-Puig
Journal:  Cancer Res       Date:  2006-04-15       Impact factor: 12.701

7.  Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial.

Authors:  Axel Grothey; Eric Van Cutsem; Alberto Sobrero; Salvatore Siena; Alfredo Falcone; Marc Ychou; Yves Humblet; Olivier Bouché; Laurent Mineur; Carlo Barone; Antoine Adenis; Josep Tabernero; Takayuki Yoshino; Heinz-Josef Lenz; Richard M Goldberg; Daniel J Sargent; Frank Cihon; Lisa Cupit; Andrea Wagner; Dirk Laurent
Journal:  Lancet       Date:  2012-11-22       Impact factor: 79.321

8.  Wig1 prevents cellular senescence by regulating p21 mRNA decay through control of RISC recruitment.

Authors:  Bong Cho Kim; Hyung Chul Lee; Je-Jung Lee; Chang-Min Choi; Dong-Kwan Kim; Jae Cheol Lee; Young-Gyu Ko; Jae-Seon Lee
Journal:  EMBO J       Date:  2012-10-19       Impact factor: 11.598

Review 9.  The Clinical Relevance of Long Non-Coding RNAs in Cancer.

Authors:  Andreia Silva; Marc Bullock; George Calin
Journal:  Cancers (Basel)       Date:  2015-10-27       Impact factor: 6.639

10.  IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis.

Authors:  Matjaz Rokavec; Meryem Gülfem Öner; Huihui Li; Rene Jackstadt; Longchang Jiang; Dmitri Lodygin; Markus Kaller; David Horst; Paul K Ziegler; Sarah Schwitalla; Julia Slotta-Huspenina; Franz G Bader; Florian R Greten; Heiko Hermeking
Journal:  J Clin Invest       Date:  2014-03-18       Impact factor: 14.808

View more
  16 in total

1.  Lnc-HZ05 regulates BPDE-inhibited human trophoblast cell proliferation and affects the occurrence of miscarriage by directly binding with miR-hz05.

Authors:  Chenyang Mi; Weina Chen; Tingting Liang; Jiayu Xie; Zhongyan Xu; Wenxin Huang; Peng Tian; Shuming Zhang; Mengyuan Dai; Huidong Zhang
Journal:  Cell Biol Toxicol       Date:  2022-01-17       Impact factor: 6.691

2.  Combination of resveratrol and BIBR1532 inhibits proliferation of colon cancer cells by repressing expression of LncRNAs.

Authors:  Bakiye Goker Bagca; Hasan Onur Caglar; Selin Cesmeli; Neslihan Pinar Ozates; Cumhur Gunduz; Cigir Biray Avci
Journal:  Med Oncol       Date:  2021-11-15       Impact factor: 3.064

3.  HOTAIR regulates colorectal cancer stem cell properties and promotes tumorigenicity by sponging miR-211-5p and modulating FLT-1.

Authors:  Ye Huang; Liang Wang; Di Liu
Journal:  Cell Cycle       Date:  2021-09-01       Impact factor: 5.173

Review 4.  LncRNAs as Regulators of Autophagy and Drug Resistance in Colorectal Cancer.

Authors:  Mercedes Bermúdez; Maribel Aguilar-Medina; Erik Lizárraga-Verdugo; Mariana Avendaño-Félix; Erika Silva-Benítez; Cesar López-Camarillo; Rosalío Ramos-Payán
Journal:  Front Oncol       Date:  2019-10-02       Impact factor: 6.244

5.  The identification of CRNDE, H19, UCA1 and HOTAIR as the key lncRNAs involved in oxaliplatin or irinotecan resistance in the chemotherapy of colorectal cancer based on integrative bioinformatics analysis.

Authors:  Fangfang Sun; Weiwei Liang; Jing Qian
Journal:  Mol Med Rep       Date:  2019-08-14       Impact factor: 2.952

6.  LncSNHG3/miR-139-5p/BMI1 axis regulates proliferation, migration, and invasion in hepatocellular carcinoma.

Authors:  Jian Wu; Lingyun Liu; Huilin Jin; Qiao Li; Shutong Wang; Baogang Peng
Journal:  Onco Targets Ther       Date:  2019-08-19       Impact factor: 4.147

7.  Prognostic Value of LncRNA HOTAIR in Colorectal Cancer: A Meta-analysis.

Authors:  Shuangqian Chen; Chunxiao Zhang; Maohui Feng
Journal:  Open Med (Wars)       Date:  2020-02-11

8.  Correlation between expression levels of lncRNA FER1L4 and RB1 in patients with colorectal cancer.

Authors:  Marjan Ostovarpour; Mohammad Khalaj-Kondori; Tayyebeh Ghasemi
Journal:  Mol Biol Rep       Date:  2021-06-16       Impact factor: 2.316

9.  Long non-coding RNA HOTAIR regulates myeloid differentiation through the upregulation of p21 via miR-17-5p in acute myeloid leukaemia.

Authors:  Linhui Hu; Jun Liu; Ye Meng; Huimin Zheng; Chen Ding; Huiping Wang; Alice Charwudzi; Manman Li; Jingrong Li; Zhimin Zhai; Shudao Xiong
Journal:  RNA Biol       Date:  2020-12-09       Impact factor: 4.652

10.  p21WAF1/Cip1 Regulation by hYSK1 Activates SP-1 Transcription Factor and Increases MMP-2 Expression under Hypoxic Conditions.

Authors:  Mee-Hyun Lee; Joydeb Kumar Kundu; Bu Young Choi
Journal:  Int J Mol Sci       Date:  2019-01-14       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.